Skip to search formSkip to main contentSkip to account menu

DPX-0907

Known as: Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907 
A lipid-based multi-peptide cancer vaccine targeted against multiple cancers with immunopotentiating activity. Therapeutic breast/ovarian/prostate… 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Cancer Vaccines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Effect of the novel therapeutic cancer vaccine formulation DPX-0907 on multifunctional T-cell responses in ovarian, breast, and prostate cancer patients.
2588 Background: To increase the efficacy of peptide cancer vaccines, we developed a novel vaccine platform called DepoVax, an… 
2011
2011
A phase I study of the safety and immunogenicity of a therapeutic vaccine, DPX-0907 in patients with advanced-stage ovarian, breast, or prostate cancer.
e13050 Background: Immunovaccine Inc. (IMV) has developed a novel liposome-in-oil depot vaccine platform called DepoVax (DPX… 
2011
2011
Abstract 5534: Evaluation of clinical safety and immunogenicity of DPX-0907, a multi-epitope vaccine for the treatment of breast, ovarian and prostate cancers
A successful cancer vaccine needs to overcome tumor-induced immune suppression while enhancing protective Type1-biased tumor… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)